Register Login

NATIONAL HEALTHCARE CORP (NHC)

Director HASSAN EMIL E 🟡 adjusted position in 30.0K shares (5 derivative) of NATIONAL HEALTHCARE CORP (NHC) at $96.03 ($3.4M) Transaction Date: Apr 30, 2026 | Filing ID: 014489

Full text
Register to leave comments
  • News bot May 1, 2026, 8:46 p.m.

    🔍 HASSAN EMIL E (Director)

    Company: NATIONAL HEALTHCARE CORP (NHC)

    Report Date: 2026-04-30

    Transaction Summary:

    • Total transactions: 6
    • Derivative instruments: 5
    • Holdings reported: 4
    • Total shares acquired: 7,500
    • Total shares sold: 7,500
    • Total shares held: 30,000

    Detailed Transactions and Holdings:

    • Acquired 7,500 shares of Shares of Common Stock at $71.64 per share (Direct)
      Date: 2026-04-30 | Code: M | equity_swap_involved: 0 | shares_owned_after: 73,095.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 7,500 shares of Option to Purchase Common Stock [2021 Grant] at $71.64 per share (Derivative)
      Date: 2026-04-30 | Code: M | Expires: 2026-05-05 | Exercise: 2022-05-06 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1
    • Holds 7,500 shares of Option to Purchase Common Stock [2022 Grant] at $69.19 per share (Derivative)
      Date: 2026-04-30 | Code: H | Expires: 2027-05-04 | Exercise: 2023-05-05 | shares_owned_after: 7,500.00
    • Holds 7,500 shares of Option to Purchase Common Stock [2023 Grant] at $55.75 per share (Derivative)
      Date: 2026-04-30 | Code: H | Expires: 2028-05-03 | Exercise: 2024-05-04 | shares_owned_after: 7,500.00
    • Holds 7,500 shares of Option to Purchase Common Stock [2024 Grant] at $96.03 per share (Derivative)
      Date: 2026-04-30 | Code: H | Expires: 2029-05-08 | Exercise: 2025-05-09 | shares_owned_after: 7,500.00
    • Holds 7,500 shares of Option to Purchase Common Stock [2025 Grant] at $94.66 per share (Derivative)
      Date: 2026-04-30 | Code: H | Expires: 2030-05-07 | Exercise: 2026-05-08 | shares_owned_after: 7,500.00

    Footnotes:

    • F1: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 6, 2021. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).

Search

News categories